Master data| INID | Criterion | Field | Content | 
|---|
|  | Type of IP right | SART | Patent | 
|  | Status | ST | Pending/in force | 
| 21 | DE file number | DAKZ | 60 2009 037 581.4 | 
| 96 | EP file number | EAKZ | 09 82 4027.8 | 
| 86 | WO file number | WAKZ | PCT/US2009/061575 | 
| 97 | EP publication number | EPN | 2362731 | 
| 87 | WO publication number | WPN | 2010051206 | 
| 54 | Designation/title | TI | NEUE NÜTZLICH ANTI-DIABETISCHE MITTEL MIT ZYKLISCHE BENZIMIDAZOL-DERIVATE | 
| 51 | IPC main class | ICM (ICMV)
 | A61K 31/366 (2006.01) | 
| 51 | IPC secondary class(es) | ICS (ICSV)
 | C07F 9/6506 (2006.01),   C07F 9/6574 (2006.01),   A61K 31/415 (2006.01),   A61K 31/397 (2006.01),   A61K 31/4184 (2006.01),   A01N 43/50 (2006.01),   A61K 31/4412 (2006.01),   A61K 45/06 (2006.01),   C07F 9/6558 (2006.01) | 
| 22 | DE application date | DAT | Oct 22, 2009 | 
| 96 | EP application date | EAT | Oct 22, 2009 | 
| 86 | WO application date | WAT | Oct 22, 2009 | 
| 43 | Date of first publication | OT | May 6, 2010 | 
|  | Date of publication of grant | PET | Apr 6, 2016 | 
| 71/73 | Applicant/owner | INH | Merck Sharp & Dohme LLC, Rahway, NJ, US; Metabasis Therapeutics, Inc., La Jolla, CA, US | 
| 72 | Inventor | IN | DANG, Qun, La JollaCalifornia 92037, US; CHUNG, De Michael, La JollaCalifornia 92037, US; GIBSON, Tony, S., La JollaCalifornia 92037, US; JIANG, Hongjian, La JollaCalifornia 92037, US; CASHION, Daniel, K., La JollaCalifornia 92037, US; BAO, Jianming, RahwayNew Jersey 07065-0907, US; LAN, Ping, RahwayNew Jersey 07065-0907, US; LU, Huagang, RahwayNew Jersey 07065-0907, US; MAKARA, Gergely, M., RahwayNew Jersey 07065-0907, US; ROMERO, F. Anthony, RahwayNew Jersey 07065-0907, US; SEBHAT, Iyassu, RahwayNew Jersey 07065-0907, US; WODKA, Dariusz, RahwayNew Jersey 07065-0907, US | 
| 74 | Representative | VTR | Abitz & Partner Patentanwälte mbB, 81925 München, DE | 
|  | Address for service |  | Abitz & Partner Patentanwälte mbB, 81628 München, DE | 
| 33 31
 32
 
 | Foreign priority | PRC PRNA
 PRDA
 
 | US 198006 P
 Oct 31, 2008
 
 | 
|  | Due date | FT FG
 | Oct 31, 2026 Annual fee for the 18th year
Patent fees
 | 
|  | Patent division in charge |  | 44 | 
| 97 | EP language of publication | ELANG | EN - Englisch | 
| 84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR | 
|  | Published EP/WO documents | EPWOPN | Original document: EP000002362731 Searchable text: 
EP000002362731
 Original document: 
EP000002362731B1
 Searchable text: 
EP000002362731B1
 Original document: 
WO002010051206
 Searchable text: 
WO002010051206
 | 
| 43 | Date of first publication | EVT | May 6, 2010 | 
|  | Date of the first transfer into DPMAregister | EREGT | Oct 21, 2011 | 
|  | Date of the (most recent) update in DPMAregister | REGT | Sep 26, 2025 (Show all update days)(Hide all update days)
 Sep 26, 2025Due date: changed
Procedures: Procedure relating to EP application, EPO publication of mention of grant , 06.04.2016: new
Procedures: Procedure relating to EP application, EPO publication of mention of grant , 06.04.2016: deleted
Sep 19, 2024Jul 20, 2024Procedures: Procedure relating to PCT application, Publication of PCT application, 06.05.2010: deleted
Sep 23, 2023; Nov 9, 2022; Sep 30, 2022; Jun 28, 2022; Sep 23, 2021; Sep 25, 2020; Sep 21, 2019; Sep 21, 2018; Nov 14, 2017; Sep 14, 2017; Apr 20, 2017; Mar 30, 2017; Mar 16, 2017; Jan 26, 2017; Nov 18, 2016; May 25, 2016; Apr 20, 2016; Apr 15, 2016; Apr 7, 2016; Feb 15, 2013Historical data not available for this/these date(s)
Oct 21, 2011
 Date of the first transfer into DPMAregister
 |